Three novel IGSF1 mutations in four Japanese patients with X-linked congenital central hypothyroidism

Akie Nakamura1, Beata Bak, Tanya L R Silander

  • 1MD, Department of Pediatrics, Hokkaido University School of Medicine, North 15 West 7, Kitaku, Sapporo, Japan 060-8635. akieda@med.hokudai.ac.jp.

Abstract

Insights

Genetic defects in the IGSF1 gene cause X-linked congenital central hypothyroidism (C-CH) and variable prolactin deficiency in boys. This study identified novel IGSF1 mutations in Japanese patients with unexplained C-CH.

Area of Science:

  • Genetics
  • Endocrinology
  • Molecular Biology

Background:

  • Congenital central hypothyroidism (C-CH) is a rare endocrine disorder.
  • The molecular basis for many C-CH cases remains unexplained.

Purpose of the Study:

  • Investigate the genetic causes of unexplained C-CH in four Japanese boys.
  • Determine the functional impact of identified mutations in the IGSF1 gene.

Main Methods:

  • Whole-exome sequencing and PCR direct sequencing were employed to identify genetic mutations.
  • Analysis of protein expression and membrane trafficking of IGSF1 variants.
  • Clinical evaluation including thyroid hormone levels and prolactin deficiency assessment.

Main Results:

  • Four Japanese boys with C-CH were found to have mutations in the IGSF1 gene.
  • Identified mutations include novel nonsense (p.R1189X, p.Q645X) and missense (p.V1082E) variants.
  • Mutations affected IGSF1 protein expression and/or its trafficking to the plasma membrane, leading to loss-of-function.

Conclusions:

  • Loss-of-function mutations in IGSF1 are a cause of X-linked C-CH.
  • IGSF1 mutations are associated with variable prolactin deficiency.
  • Genetic analysis of IGSF1 is crucial for diagnosing certain forms of congenital hypothyroidism.

Related Concept Videos

Hypothyroidism II: Pathophysiology01:23

Hypothyroidism II: Pathophysiology

Hypothyroidism is a disorder characterized by insufficient production of thyroid hormones, which regulate metabolism, energy balance, and multiple organ systems.TypesHypothyroidism is classified based on the level of dysfunction. Primary hypothyroidism results from intrinsic thyroid gland dysfunction, causing reduced hormone production despite normal or increased stimulation. Secondary hypothyroidism arises from inadequate thyroid-stimulating hormone (TSH) secretion by the pituitary. Tertiary...
Hyperthyroidism II: Pathophysiology01:27

Hyperthyroidism II: Pathophysiology

Hyperthyroidism is a hypermetabolic state caused by elevated levels of thyroid hormones, triiodothyronine (T3) and thyroxine (T4). It results from dysregulation at the thyroid, pituitary, or immune system level and affects multiple organ systems.PathophysiologyThe most common cause of hyperthyroidism is Graves’ disease, an autoimmune disorder in which antibodies, specifically thyroid-stimulating antibodies (TSAb), a subtype of TSH receptor antibodies (TRAb), bind to and activate TSH receptors...
Synthesis and Regulation of Thyroid Hormones01:20

Synthesis and Regulation of Thyroid Hormones

Low blood levels of the thyroid hormones — triiodothyronine (T3) and thyroxine (T4) — signal the hypothalamus to release the thyrotropin-releasing hormone (TRH). TRH then reaches the pituitary gland and stimulates the release of thyroid-stimulating hormone(TSH) into the bloodstream.
Upon reaching the thyroid gland, TSH stimulates the follicular cells' active uptake of iodide ions from the blood. The ions diffuse to the apical surface of the cells and are oxidized to iodine. The iodine is then...
Graves' Disease I: Introduction01:28

Graves' Disease I: Introduction

Graves' disease is an autoimmune disorder that causes hyperthyroidism, or overactivity of the thyroid gland. It results from autoantibodies called thyroid-stimulating immunoglobulins (TSIs), which bind to thyroid-stimulating hormone (TSH) receptors, leading to overstimulation of hormone production and a hypermetabolic state.EtiologyAlthough considered idiopathic, Graves’ disease has well-established contributing factors. There is a strong genetic component, with increased prevalence in...